Health And Marketing Protocols For Msme Angkringan Traders In Diro Village Bantul
DOI:
https://doi.org/10.59247/jppmi.v3i9.236Keywords:
Marketing Strategy, Angkringan, Small And Medium Enterprises, Health Protocols, Digital MarketingAbstract
Micro, Small and Medium Enterprises is one of the fields that makes a significant contribution to spurring Indonesia's economic growth. SMEs in Indonesia still face various promotional and marketing problems. Angkringan is a place that sells simple food that does not recognize social strata. As information and communication technology develops, it has been used for online product marketing. Online product marketing has many advantages, namely wide coverage, does not know time and space, can be done anytime and anywhere. Pak Nardi's Angkringan doesn't understand online marketing strategies and health protocols, so it needs to get training. With education on health protocols and online marketing, it is hoped that partners can implement health protocols well and can manage online marketing accounts independently. This activity aims to find strategies to improve the implementation of health protocols and increase online sales turnover. The methods used are offline and online mentoring and education. As a result of this assistance, angkringan business actors can improve their health protocol discipline and can market their products online, so that sales turnover increases. The conclusion obtained is that by providing educational assistance on health protocols and online marketing strategies, business actors can improve health protocol discipline and can market their products online, so that sales turnover increases.
References
A. M. Tsonas et al., “Practice of tracheostomy in patients with acute respiratory failure related to COVID–19 – Insights from the PRoVENT–COVID study,” Pulmonology, vol. 28, no. 1, pp. 18–27, Jan. 2022.
T. Aparicio et al., “Effect of lockdown on digestive system cancer care amongst older patients during the first wave of COVID-19: The CADIGCOVAGE multicentre cohort study,” Dig. Liver Dis., vol. 54, no. 1, pp. 10–18, Jan. 2022.
T. Millard et al., “Awareness, value and use of the Australian living guidelines for the clinical care of people with COVID-19: an impact evaluation,” J. Clin. Epidemiol., vol. 143, pp. 11–21, Mar. 2022.
A. Håkansson and E. Claesdotter, “Fear of COVID-19, compliance with recommendations against virus transmission, and attitudes towards vaccination in Sweden,” Heliyon, vol. 8, no. 1, p. e08699, Jan. 2022.
Y. Miki, N. Chubachi, F. Imamura, N. Yaegashi, and K. Ito, “Impact of COVID-19 restrictions on the research environment and motivation of researchers in Japan,” Prog. Disaster Sci., vol. 8, p. 100128, Dec. 2020.
F. López-Medrano et al., “Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study,” Int. J. Infect. Dis., vol. 105, pp. 487–494, Apr. 2021.
A. J. Einstein et al., “International Impact of COVID-19 on the Diagnosis of Heart Disease,” J. Am. Coll. Cardiol., vol. 77, no. 2, pp. 173–185, Jan. 2021.
N. Hoertel et al., “Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in France,” Biol. Psychiatry Glob. Open Sci., vol. 3, no. 1, pp. 56–67, Jan. 2023.
X. Hu, L. Sun, Z. Guo, C. Wu, X. Yu, and J. Li, “Management of COVID-19 patients with chronic liver diseases and liver transplants,” Ann. Hepatol., vol. 27, no. 1, p. 100653, Jan. 2022.
I. C. Kreft et al., “Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model,” Thromb. Res., vol. 210, no. November 2021, pp. 6–11, Feb. 2022.
C. A. Ackley, D. J. Lundberg, L. Ma, I. T. Elo, S. H. Preston, and A. C. Stokes, “County-level estimates of excess mortality associated with COVID-19 in the United States,” SSM - Popul. Heal., vol. 17, p. 101021, Mar. 2022.
S. Brinkman et al., “Comparison of outcome and characteristics between 6343 COVID-19 patients and 2256 other community-acquired viral pneumonia patients admitted to Dutch ICUs,” J. Crit. Care, vol. 68, pp. 76–82, Apr. 2022.
J.-P. Roozeman et al., “Prognostication using SpO2/FiO2 in invasively ventilated ICU patients with ARDS due to COVID-19 – Insights from the PRoVENT-COVID study,” J. Crit. Care, vol. 68, pp. 31–37, Apr. 2022.
N. S. Nurmohamed et al., “Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study,” Atherosclerosis, vol. 341, no. July 2021, pp. 43–49, Jan. 2022.
H. Allen et al., “Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study,” Lancet Reg. Heal. - Eur., vol. 12, no. May, p. 100252, Jan. 2022.
C. Nwakasi, D. Esiaka, I. Uchendu, and S. Bosun-Arije, “Factors influencing compliance with public health directives and support for government’s actions against COVID-19: A Nigerian case study,” Sci. African, vol. 15, p. e01089, Mar. 2022.
R. Vrba, L. Lubuska, and P. Spicka, “Hybrid transthoracic oesophagectomy due to carcinoma with complications after COVID-19 pneumonia – A case report,” Int. J. Surg. Case Rep., vol. 90, no. November 2021, p. 106749, Jan. 2022.
L. Bergamaschi et al., “Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease,” Immunity, vol. 54, no. 6, pp. 1257-1275.e8, Jun. 2021.
S. Grassin-Delyle et al., “Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study,” EBioMedicine, vol. 63, p. 103154, Jan. 2021.
A. Miethke-Morais et al., “COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors,” Brazilian J. Infect. Dis., vol. 25, no. 4, p. 101609, Jul. 2021.
G. C. Barron et al., “Safeguarding people living in vulnerable conditions in the COVID-19 era through universal health coverage and social protection,” Lancet Public Heal., vol. 7, no. 1, pp. e86–e92, Jan. 2022.
E. Toes-Zoutendijk et al., “Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands,” Eur. J. Cancer, vol. 161, pp. 38–43, Jan. 2022.
S. Ekström et al., “General Stress Among Young Adults with Asthma During the COVID-19 Pandemic,” J. Allergy Clin. Immunol. Pract., vol. 10, no. 1, pp. 108–115, Jan. 2022.
T. W. Russell, J. T. Wu, S. Clifford, W. J. Edmunds, A. J. Kucharski, and M. Jit, “Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study,” Lancet Public Heal., vol. 6, no. 1, pp. e12–e20, Jan. 2021.
F. S. Taccone et al., “The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium,” Lancet Reg. Heal. - Eur., vol. 2, p. 100019, Mar. 2021.
M. Montalti et al., “ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance,” EClinicalMedicine, vol. 000, p. 101027, Jul. 2021.
S. Yegorov et al., “Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study,” Lancet Reg. Heal. - Eur., vol. 4, p. 100096, May 2021.
P. Serrano-Lorenzo et al., “Plasma LDH: A specific biomarker for lung affectation in COVID-19?,” Pract. Lab. Med., vol. 25, no. July 2020, p. e00226, May 2021.
K. M. McCarthy et al., “The importation and establishment of community transmission of SARS-CoV-2 during the first eight weeks of the South African COVID-19 epidemic,” EClinicalMedicine, vol. 39, p. 101072, Sep. 2021.
M. Martínez-Lacalzada et al., “Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model,” Clin. Microbiol. Infect., no. xxxx, pp. 1–7, Jul. 2021.
L. E. Wearick-Silva, S. A. Richter, T. W. Viola, and M. L. Nunes, “Sleep quality among parents and their children during COVID-19 pandemic in a Southern - Brazilian sample,” J. Pediatr. (Rio. J)., Aug. 2021.
C. V. Munayco et al., “Early transmission dynamics of COVID-19 in a southern hemisphere setting: Lima-Peru: February 29th–March 30th, 2020,” Infect. Dis. Model., vol. 5, pp. 338–345, 2020.
M. Panel and T. Third, “Multidisciplinary, three-dimensional and individualized comprehensive treatment for severe/critical COVID-19,” Liver Res., vol. 4, no. 3, pp. 109–117, Sep. 2020.
T. W. van de Berg et al., “Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability,” Thromb. Res., vol. 201, no. January, pp. 84–89, May 2021.
S. Salto-Alejandre et al., “Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort,” Biomed. Pharmacother., vol. 146, no. December 2021, p. 112572, Feb. 2022.
F. Lazar Neto et al., “Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study,” Clin. Microbiol. Infect., vol. 27, no. 7, pp. 1037.e1-1037.e8, Jul. 2021.
R. C. Schoonbeek et al., “Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis,” Radiother. Oncol., vol. 167, pp. 42–48, Feb. 2022.
E. Sancho Ferrando, K. Hanslin, M. Hultström, A. Larsson, R. Frithiof, and M. Lipcsey, “Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study,” Cytokine, vol. 149, no. September 2021, p. 155727, Jan. 2022.
J. L. Jezmir et al., “Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United States,” Cell Reports Med., vol. 2, no. 9, p. 100376, Sep. 2021.
E. Caronna et al., “Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications,” Neurología, vol. 36, no. 8, pp. 611–617, Oct. 2021.
J. Kostenzer, J. Hoffmann, C. von Rosenstiel-Pulver, A. Walsh, L. J. I. Zimmermann, and S. Mader, “Neonatal care during the COVID-19 pandemic - a global survey of parents’ experiences regarding infant and family-centred developmental care,” EClinicalMedicine, vol. 39, p. 101056, Sep. 2021.
J. Fadista et al., “Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity,” EBioMedicine, vol. 65, p. 103277, Mar. 2021.
S. Caillard et al., “Clinical Utility of Biochemical Markers for the Prediction of COVID-19−Related Mortality in Kidney Transplant Recipients,” Kidney Int. Reports, vol. 6, no. 10, pp. 2689–2693, Oct. 2021.
I. D. Lestantri, N. B. Janom, R. S. Aris, and Y. Husni, “ScienceDirect ScienceDirect The perceptions towards the digital sharing economy among SMEs : The perceptions towards the digital sharing Preliminary findings economy among SMEs : Preliminary findings,” Procedia Comput. Sci., vol. 197, no. 2021, pp. 82–91, 2022.
A. Turkyilmaz, D. Dikhanbayeva, Z. Suleiman, S. Shaikholla, and E. Shehab, “Industry 4.0: Challenges and opportunities for Kazakhstan SMEs,” Procedia CIRP, vol. 96, pp. 213–218, 2020.
A. Nasar, M. Akram, M. R. Safdar, and M. S. Akbar, “A qualitative assessment of entrepreneurship amidst COVID-19 pandemic in Pakistan,” Asia Pacific Manag. Rev., no. xxxx, 2021.
M. Hulla, P. Herstätter, M. Wolf, and C. Ramsauer, “Towards digitalization in production in SMEs – A qualitative study of challenges, competencies and requirements for trainings,” Procedia CIRP, vol. 104, pp. 887–892, 2021.
P. V. Nguyen, H. T. N. Huynh, L. N. H. Lam, T. B. Le, and N. H. X. Nguyen, “The impact of entrepreneurial leadership on SMEs’ performance: the mediating effects of organizational factors,” Heliyon, vol. 7, no. 6, p. e07326, Jun. 2021.
C. Karakosta, Z. Mylona, J. Karásek, A. Papapostolou, and E. Geiseler, “Tackling covid-19 crisis through energy efficiency investments: Decision support tools for economic recovery,” Energy Strateg. Rev., vol. 38, no. November, 2021.
E. Woźniak and A. Tyczewska, “Bioeconomy during the COVID-19 and perspectives for the post-pandemic world: Example from EU,” EFB Bioeconomy J., vol. 1, no. March, p. 100013, 2021.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Idiani Darmawati, Ratna Indriawati, Iswanto Suwarno
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
